Joe Deaux
PersonHeard in 4 episodes across 1 show since Aug 2026
Joe Deaux is a professional journalist and reporter who covers financial markets and commodities. He has appeared as a guest on financial podcasts, including 'Stock Movers', to discuss market trends and stock movements.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 4 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
What Joe Deaux has said on podcasts
3 statements
The 30-year Treasury yield remained near its highest level since 2007.
“the 30 year yield, 5.2.8% still sitting near the high since 2007”
Open the episode · Closing Bell: Amylyx Pharmaceuticals Climbs, Targa Rises, Klarna PlungesListen at 5:03
EyePoint’s experimental eye-disease treatment failed its late-stage primary endpoint.
“the drug developer said its experimental treatment for an eye disease failed to meet a primary goal in its late stage trial.”
Open the episode · Closing Bell: Chip Stocks Rise, SpaceX Gains, EyePoint SinksListen at 3:15
EyePoint’s failed trial does not necessarily end its prospects.
“that doesn't necessarily mean this is the end.”
Open the episode · Closing Bell: Chip Stocks Rise, SpaceX Gains, EyePoint SinksListen at 3:46
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring Joe Deaux, newest first
- Aug 20, 2026
Walmart’s miss exposes pressure on retail growthStock MoversAug 20, 2026 - Aug 18, 2026
Amylyx surges on trial success while Klarna plunges on weak guidanceStock MoversAug 18, 2026Guest - Aug 17, 2026
AI stocks climb as Treasuries sell offStock MoversAug 17, 2026Guest - Aug 17, 2026
AI chip rally collides with biotech failure and bond-market stressStock MoversAug 17, 2026Guest